NewsFDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammationAuthor:Ralph EllisPublish date: August 25, 2020The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.Read More
